empagliflozin/linagliptin

empagliflozin/linagliptin is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Pronunciation:
em-pag-gli-floe-zin/lin-a-glip-tin


Trade Name(s)

  • Glyxambi

Ther. Class.
antidiabetics

Pharm. Class.
sodium-glucose co-transporter 2 (SGLT2) inhibitors
dipeptidyl peptidase-4 (DDP-4) inhibitors

-- To view the remaining sections of this topic, please or --

General

Pronunciation:
em-pag-gli-floe-zin/lin-a-glip-tin


Trade Name(s)

  • Glyxambi

Ther. Class.
antidiabetics

Pharm. Class.
sodium-glucose co-transporter 2 (SGLT2) inhibitors
dipeptidyl peptidase-4 (DDP-4) inhibitors

There's more to see -- the rest of this entry is available only to subscribers.